On November 11, 2022 Biomea Fusion, Inc. ("Biomea")(Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with genetically defined cancers and metabolic diseases, reported that Biomea’s management will participate in a fireside chat and host investor meetings at the upcoming Piper Sandler 34th Annual Healthcare Conference (Press release, Biomea Fusion, NOV 11, 2022, View Source [SID1234623836]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Sandler 34th Annual Healthcare Conference
Location: New York, NY
Fireside Chat: Tuesday, November 29, 2022, at 3:30 pm ET
1×1 Meetings: Tuesday, November 29, 2022

A webcast of the fireside chat will be available on the investor page of Biomea’s website at View Source